September 07, 2011 at 16:00 PM EDT
Alkermes’ Corporate Presentation to be Webcast at Two Upcoming Conferences

Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live from the Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2011, at 10:20 a.m. ET. In addition, Alkermes’ corporate presentation will be webcast live from the UBS Global Life Sciences Conference on Wednesday, September 21, 2011, at 2:30 p.m. ET. Both presentations will be webcast from the Grand Hyatt Hotel in New York City. The presentations may be accessed at www.alkermes.com. The presentations will be archived for 14 days.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients’ lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol and opioid dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes’ robust pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.

Contacts:

Alkermes, Inc.
Eva Stroynowski, 781-609-6823
Corporate Communications
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here